Physician profile
Robert A Macleod
NPI 1821319856
$11,260.24
in general payments reported to CMS, 2019-2025
17 companies · $3,811 in 2025
The $3,811 reported for 2025 was more than what 78% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,954 · 2020: $2,480 · 2021: $172 · 2023: $1,698 · 2024: $145 · 2025: $3,811.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,827 · Food and Beverage: $1,827.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,826.51 |
| Food and Beverage | $1,827.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Midsouth Orthopedics INC. | $3,538.89 | 2019-2025 | |
| Arthrex, INC. | $3,464.64 | 2020-2025 | |
| Medical Device Business Services, INC. | $1,447.03 | 2019 | |
| Stryker Corporation | $1,107.25 | 2025 | Mako |
| Zimmer Biomet Holdings, INC. | $864.14 | 2025 | Comprehensive Shoulder System |
| Depuy Synthes Sales INC. | $203.03 | 2019-2025 | Motoband |
| Horizon Therapeutics Plc | $151.06 | 2020-2021 | |
| Smith+Nephew, INC. | $119.48 | 2020-2021 | |
| Innovation Technologies INC | $103.15 | 2023 | Irrisept |
| Heron Therapeutics, INC. | $83.92 | 2025 | Zynrelef |
| Anika Therapeutics, INC. | $68.06 | 2023 | Total Anika, Wristmotion, Tactoset |
| Vertex Pharmaceuticals Incorporated | $34.73 | 2025 | |
| Bioventus LLC | $17.15 | 2019 | |
| Kci USA, INC. | $16.14 | 2021 | |
| Pacira Therapeutics, INC. | $15.93 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $15.55 | 2020 | |
| Kinex Medical Company LLC | $10.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Macleod listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.